3,424
Views
44
CrossRef citations to date
0
Altmetric
Report

Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products

, , , , , , & show all
Pages 761-774 | Published online: 02 Oct 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Qing An, Yingxin Zheng, Yirong Zhao, Tao Liu, Huaizu Guo, Dapeng Zhang, Weizhu Qian, Hao Wang, Yajun Guo, Sheng Hou & Jing Li. (2019) Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system. Drug Design, Development and Therapy 13, pages 791-805.
Read now
Brian Hassett, Morton Scheinberg, Gilberto Castañeda-Hernández, Mengtao Li, Uppuluri R K Rao, Ena Singh, Ehab Mahgoub, Javier Coindreau, Julie O'Brien, Steven M Vicik & Brian Fitzpatrick. (2018) Variability of intended copies for etanercept (Enbrel®): Data on multiple batches of seven products. mAbs 10:1, pages 166-176.
Read now
François Griaud, Andrej Winter, Blandine Denefeld, Manuel Lang, Héloïse Hensinger, Frank Straube, Mirko Sackewitz & Matthias Berg. (2017) Identification of multiple serine to asparagine sequence variation sites in an intended copy product of LUCENTIS® by mass spectrometry. mAbs 9:8, pages 1337-1348.
Read now
Yongjing Cheng, Feng Yang, Cibo Huang, Jia Huang, Qian Wang, Yingjuan Chen, Yingjue Du, Like Zhao, Ming Gao & Fang Wang. (2017) Plasmapheresis therapy in combination with TNF-α inhibitor and DMARDs: A multitarget method for the treatment of rheumatoid arthritis. Modern Rheumatology 27:4, pages 576-581.
Read now
Lei Zhang, Shen Luo & Baolin Zhang. (2016) The use of lectin microarray for assessing glycosylation of therapeutic proteins. mAbs 8:3, pages 524-535.
Read now
Alain Beck & Janice M. Reichert. (2013) Approval of the first biosimilar antibodies in Europe. mAbs 5:5, pages 621-623.
Read now
Brian Hassett, Scott McMillen & Brian Fitzpatrick. (2013) Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products. mAbs 5:5, pages 624-625.
Read now
Daniel Ayoub, Wolfgang Jabs, Anja Resemann, Waltraud Evers, Catherine Evans, Laura Main, Carsten Baessmann, Elsa Wagner-Rousset, Detlev Suckau & Alain Beck. (2013) Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques. mAbs 5:5, pages 699-710.
Read now

Articles from other publishers (36)

Patanachai K. Limpikirati, Sorrayut Mongkoltipparat, Thinnaphat Denchaipradit, Nathathai Siwasophonpong, Wudthipong Pornnopparat, Parawan Ramanandana, Phumrapee Pianpakt, Songsak Tongchusak, Maoxin Tim Tian & Trairak Pisitkun. (2023) Basic Regulatory Science Behind Drug Substance and Drug Product Specifications of Monoclonal Antibodies and Other Protein Therapeutics. Journal of Pharmaceutical Analysis.
Crossref
Xiaomei Liu, Zelan Yang, Chenglong Liu, Bo Xu, Xueqing Wang, Yang Li, Jing Xia, Danni Li, Can Zhang, Hui Sun & Qing Yang. (2023) Identification of a type II LacNAc specific binding lectin CMRBL from Cordyceps militaris. International Journal of Biological Macromolecules 230, pages 123207.
Crossref
Björn‐Hendrik Peters, James Bautista, Thomas R. Slaney, Hongyue Guo, Richard Y.‐C. Huang, Mary E. Krause, Ming Zeng, Julie Cheng & Zhi Chen. (2022) Enzymatic removal of sialic acid enables iCIEF stability monitoring of charge variants of a highly sialylated bispecific antibody. ELECTROPHORESIS 43:9-10, pages 1059-1067.
Crossref
Neh Nupur, Srishti Joshi, Davy Gulliarme & Anurag S. Rathore. (2022) Analytical Similarity Assessment of Biosimilars: Global Regulatory Landscape, Recent Studies and Major Advancements in Orthogonal Platforms. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Bastiaan L. Duivelshof, Amarande Murisier, Julien Camperi, Szabolcs Fekete, Alain Beck, Davy Guillarme & Valentina D'Atri. (2020) Therapeutic Fc‐fusion proteins: Current analytical strategies. Journal of Separation Science 44:1, pages 35-62.
Crossref
Ohnmar Khanal, Vijesh Kumar & Abraham M. Lenhoff. (2020) Displacement to separate host‐cell proteins and aggregates in cation‐exchange chromatography of monoclonal antibodies. Biotechnology and Bioengineering 118:1, pages 164-174.
Crossref
Ali M. Alsamil, Thijs J. Giezen, Toine C. Egberts, Hubert G. Leufkens, Arnold G. Vulto, Martijn R. van der Plas & Helga Gardarsdottir. (2020) Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review. European Journal of Pharmaceutical Sciences 154, pages 105501.
Crossref
Raquel Pérez-Robles, Luis Cuadros-Rodríguez, Antonio Salmerón-García, José Cabeza-Barrera & Natalia Navas. (2020) Intact charge variant analysis of ziv-aflibercept by cationic exchange liquid chromatography as a proof of concept: Comparison between volatile and non-volatile salts in the mobile phase. Journal of Pharmaceutical and Biomedical Analysis 185, pages 113233.
Crossref
Bertie Chi, Christel Veyssier, Toyin Kasali, Faisal Uddin & Christopher A. Sellick. (2020) At-line high throughput site-specific glycan profiling using targeted mass spectrometry. Biotechnology Reports 25, pages e00424.
Crossref
Amandine Boeuf, François Debaene, Daniel Ayoub, Hélène Diemer, Anthony Ehkirch, Elsa Wagner‐Rousset, Alain Van Dorsselaer, Sarah Cianférani & Alain Beck. 2020. Structural Biology in Drug Discovery. Structural Biology in Drug Discovery 503 519 .
Ramesh Jois, Sukumar Mukherjee, S Rajeswari, PD Rath, Vishal Goyal & Disha Gupta. (2020) Similar biologics in India: A story of access or potential for compromise?. Indian Journal of Medical Research 152:5, pages 456.
Crossref
Jukyung Kang, Troy Halseth, Daniel Vallejo, Zeynab Izadi Najafabadi, K. Ilker Sen, Michael Ford, Brandon T. Ruotolo & Anna Schwendeman. (2019) Assessment of biosimilarity under native and heat-stressed conditions: rituximab, bevacizumab, and trastuzumab originators and biosimilars. Analytical and Bioanalytical Chemistry 412:3, pages 763-775.
Crossref
Weston B Struwe & Carol V Robinson. (2019) Relating glycoprotein structural heterogeneity to function – insights from native mass spectrometry. Current Opinion in Structural Biology 58, pages 241-248.
Crossref
Li-Juan Huang, Chia-Wang Chiang, Shun-Li Chen, Shih-Yao Wei & Shu-Hui Chen. (2019) Complete mapping of disulfide linkages for etanercept products by multi-enzyme digestion coupled with LC-MS/MS using multi-fragmentations including CID and ETD. Journal of Food and Drug Analysis 27:2, pages 531-541.
Crossref
Ramin Fazel, Yudong Guan, Behrouz Vaziri, Christoph Krisp, Laura Heikaus, Amirhossein Saadati, Siti Nurul Hidayah, Manasi Gaikwad & Hartmut Schlüter. (2019) Structural and In Vitro Functional Comparability Analysis of Altebrel™, a Proposed Etanercept Biosimilar: Focus on Primary Sequence and Glycosylation. Pharmaceuticals 12:1, pages 14.
Crossref
Viktor Háda, Attila Bagdi, Zsolt Bihari, Sarolta Baginé Timári, Ádám Fizil & Csaba SzántayJr.Jr.. (2018) Recent advancements, challenges, and practical considerations in the mass spectrometry-based analytics of protein biotherapeutics: A viewpoint from the biosimilar industry. Journal of Pharmaceutical and Biomedical Analysis 161, pages 214-238.
Crossref
Sara Žigon-Branc, Ariana Barlič, Miomir Knežević, Matjaž Jeras & Gordana Vunjak-Novakovic. (2018) Testing the potency of anti-TNF-α and anti-IL-1β drugs using spheroid cultures of human osteoarthritic chondrocytes and donor-matched chondrogenically differentiated mesenchymal stem cells. Biotechnology Progress 34:4, pages 1045-1058.
Crossref
Amy Farrell, Sara Carillo, Kai Scheffler, Ken Cook & Jonathan Bones. (2018) Monoclonal antibody sequence assessment using a hybrid quadrupole-Orbitrap mass spectrometer. Analytical Methods 10:25, pages 3100-3109.
Crossref
Sara M. Shatat, Basma M. Eltanany, Abeer A. Mohamed, Medhat A. Al-Ghobashy, Faten A. Fathalla & Samah S. Abbas. (2018) Coupling of on-column trypsin digestion–peptide mapping and principal component analysis for stability and biosimilarity assessment of recombinant human growth hormone. Journal of Chromatography B 1072, pages 105-115.
Crossref
Meenu Wadhwa, Chris Bird, Paula Dilger, Peter Rigsby, Haiyan Jia & Marie Emmanuelle Behr Gross. (2017) Establishment of the first WHO International Standard for etanercept, a TNF receptor II Fc fusion protein: Report of an international collaborative study. Journal of Immunological Methods 447, pages 14-22.
Crossref
Eric Largy, Fabrice Cantais, Géry Van Vyncht, Alain Beck & Arnaud Delobel. (2017) Orthogonal liquid chromatography–mass spectrometry methods for the comprehensive characterization of therapeutic glycoproteins, from released glycans to intact protein level. Journal of Chromatography A 1498, pages 128-146.
Crossref
Jandhyam Srikanth, Rathinasamy Agalyadevi & Ponnusamy Babu. (2016) Targeted, Site-specific quantitation of N- and O-glycopeptides using 18O–labeling and product ion based mass spectrometry. Glycoconjugate Journal 34:1, pages 95-105.
Crossref
Li-Juan Huang, Chia-Wang Chiang, Yu-Wen Lee, Tzu-Fan Wang, Ching-Chu Fong & Shu-Hui Chen. (2016) Characterization and comparability of stress-induced oxidation and deamidation on vulnerable sites of etanercept products. Journal of Chromatography B 1032, pages 189-197.
Crossref
L. Puig, G. Carretero, E. Daudén, C. Ferrándiz, S.E. Marrón, A. Martorell, B. Pérez-Suárez, C. Rodriguez-Cerdeira, R. Ruiz-Villaverde, J.L. Sánchez-Carazo & M. Velasco. (2015) Biosimilars in Dermatology: Current Situation (Part II). Actas Dermo-Sifiliográficas (English Edition) 106:7, pages 550-554.
Crossref
L. Puig, G. Carretero, E. Daudén, C. Ferrándiz, S.E. Marrón, A. Martorell, B. Pérez-Suárez, C. Rodriguez-Cerdeira, R. Ruiz-Villaverde, J.L. Sánchez-Carazo & M. Velasco. (2015) Biosimilares en dermatología. Situación actual (parte ii). Actas Dermo-Sifiliográficas 106:7, pages 550-554.
Crossref
Jennifer D. Könitzer, Markus M. Müller, Germán Leparc, Martin Pauers, Jan Bechmann, Patrick Schulz, Jochen Schaub, Barbara Enenkel, Tobias Hildebrandt, Martin Hampel & Anne B. Tolstrup. (2015) A global RNA-seq-driven analysis of CHO host and production cell lines reveals distinct differential expression patterns of genes contributing to recombinant antibody glycosylation. Biotechnology Journal 10:9, pages 1412-1423.
Crossref
Kyung Hyun Min & Gyun Min Lee. (2015) Purification of TNFR-Fc produced in recombinant CHO cells: Characterization of product-related impurities. Process Biochemistry 50:8, pages 1313-1317.
Crossref
Ariana Barlič, Sara Žigon, Andrej Blejec & Nevenka Kregar Velikonja. (2015) Gene expression of cultured human chondrocytes as a model for assessing neutralization efficacy of soluble TNFα by TNFα antagonists. Biologicals 43:3, pages 171-180.
Crossref
Valderilio F. Azevedo, Nathalia Galli, Alais Kleinfelder, Julia D’Ippolito & Paulo C. M. Urbano. (2014) Etanercept biosimilars. Rheumatology International 35:2, pages 197-209.
Crossref
Alain Beck, François Debaene, Hélène Diemer, Elsa Wagner-Rousset, Olivier Colas, Alain Van Dorsselaer & Sarah Cianférani. (2015) Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies. Journal of Mass Spectrometry 50:2, pages 285-297.
Crossref
Ling Hua, Xin Gao, Xiaopan Yang, Deyou Wan, Chunpeng He, Jiyue Cao & Haifeng Song. (2014) Highly efficient production of peptides: N-glycosidase F for N-glycomics analysis. Protein Expression and Purification 97, pages 17-22.
Crossref
Koen Sandra, Isabel Vandenheede & Pat Sandra. (2014) Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization. Journal of Chromatography A 1335, pages 81-103.
Crossref
Esohe Idusogie & Michael Mulkerrin. 2014. Therapeutic Fc‐Fusion Proteins. Therapeutic Fc‐Fusion Proteins 191 216 .
Stephane Houel, Mark Hilliard, Ying Qing Yu, Niaobh McLoughlin, Silvia Millan Martin, Pauline M. Rudd, Jonathan P. WilliamsWeibin Chen. (2013) N- and O-Glycosylation Analysis of Etanercept Using Liquid Chromatography and Quadrupole Time-of-Flight Mass Spectrometry Equipped with Electron-Transfer Dissociation Functionality. Analytical Chemistry 86:1, pages 576-584.
Crossref
Maria-Jose Cuadrado, Savino Sciascia, Xavier Bosch, Munther A. Khamashta & Manuel Ramos-Casals. (2013) Is it time for biosimilars in autoimmune diseases?. Autoimmunity Reviews 12:10, pages 954-957.
Crossref
Alain Beck, Hélène Diemer, Daniel Ayoub, François Debaene, Elsa Wagner-Rousset, Christine Carapito, Alain Van Dorsselaer & Sarah Sanglier-Cianférani. (2013) Analytical characterization of biosimilar antibodies and Fc-fusion proteins. TrAC Trends in Analytical Chemistry 48, pages 81-95.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.